Angen Liu
Overview
Explore the profile of Angen Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
1263
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Liu A, Pollard K
Adv Exp Med Biol
. 2015 Oct;
864:55-68.
PMID: 26420613
A biobank is an entity that collects, processes, stores, and distributes biospecimens and relevant data for use in basic, translational, and clinical research. Biobanking of high-quality human biospecimens such as...
12.
Feng Y, Minca E, Lanigan C, Liu A, Zhang W, Yin L, et al.
J Thorac Oncol
. 2014 Apr;
9(5):646-53.
PMID: 24722154
Introduction: Overexpression of MET receptor tyrosine kinase and its ligand hepatocyte growth factor (HGF) and MET gene amplification have been well-documented in non-small-cell lung cancer (NSCLC). Activated MET signaling plays...
13.
Liu A
Clin Biochem
. 2013 Dec;
47(4-5):293-9.
PMID: 24373923
High quality human biospecimens, such as tissue, blood, cell derivatives, and associated patient clinical information, are key elements of a scientific infrastructure that supports discovery and identification of molecular biomarkers...
14.
Saddoughi S, Gencer S, Peterson Y, Ward K, Mukhopadhyay A, Oaks J, et al.
EMBO Mol Med
. 2012 Nov;
5(1):105-21.
PMID: 23180565
Mechanisms that alter protein phosphatase 2A (PP2A)-dependent lung tumour suppression via the I2PP2A/SET oncoprotein are unknown. We show here that the tumour suppressor ceramide binds I2PP2A/SET selectively in the nucleus...
15.
Beckham T, Lu P, Cheng J, Zhao D, Turner L, Zhang X, et al.
Int J Cancer
. 2012 Feb;
131(9):2034-43.
PMID: 22322590
Invasiveness is one of the key features of aggressive prostate cancer; however, our understanding of the precise mechanisms effecting invasion remains limited. The ceramide hydrolyzing enzyme acid ceramidase (AC), overexpressed...
16.
Talwar S, Jin J, Carroll B, Liu A, Gillespie M, Palanisamy V
J Biol Chem
. 2011 Jul;
286(37):32333-43.
PMID: 21795698
Altered expression of RNA-binding proteins modulates gene expression in association with mRNAs encoding many proto-oncogenes, cytokines, chemokines, and proinflammatory factors. Hu antigen R (HuR), a ubiquitously expressed protein, controls a...
17.
Tan Y, Ma S, Wang F, Meng H, Mei C, Liu A, et al.
Oncol Rep
. 2011 Jun;
26(4):853-9.
PMID: 21687958
Gallbladder cancer is the most common malignant tumor of the biliary tract. Early diagnosis of gallbladder cancer is difficult because of the latent onset and lack of good biomarkers. To...
18.
Gopal U, Bohonowych J, Lema-Tome C, Liu A, Garrett-Mayer E, Wang B, et al.
PLoS One
. 2011 Mar;
6(3):e17649.
PMID: 21408136
Background: Extracellular Hsp90 protein (eHsp90) potentiates cancer cell motility and invasion through a poorly understood mechanism involving ligand mediated function with its cognate receptor LRP1. Glioblastoma multiforme (GBM) represents one...
19.
Silencing mitogen-activated protein kinase-activated protein kinase-2 arrests inflammatory bone loss
Li Q, Yu H, Zinna R, Martin K, Herbert B, Liu A, et al.
J Pharmacol Exp Ther
. 2010 Dec;
336(3):633-42.
PMID: 21139061
p38 mitogen-activated protein kinases (MAPKs) are critical for innate immune signaling and subsequent cytokine expression in periodontal inflammation and bone destruction. In fact, previous studies show that systemic p38 MAPK...
20.
Liu A
J Biomol Tech
. 2010 Sep;
21(3):120-5.
PMID: 20808641
An important need of many cancer research projects is the availability of high-quality, appropriately selected tissue. Tissue biorepositories are organized to collect, process, store, and distribute samples of tumor and...